Search Results 1061-1070 of 15784 for syphilis
Publications · Syc-Mazurek SB, Zhao-Fleming H, Guo Y, Tisavipat N, Chen JJ, Zekeridou A, Kournoutas I, Orme JJ, Block MS, Lucchinetti CF, Mustafa R, Flanagan EP.
Sykora D, Churchill RA, Hodge DO, Callori S, Houghton DE, McBane RD, Wysokinski WE. Pulmonary vein thrombosis: Clinical presentation and outcomes. Thromb Res.
Subscribe to updates. Triannual publication focused on trends and advances in pulmonary medicine at Mayo Clinic. Read Recent Issues. Email Address* ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic. Give Today · Find a doctor · Explore careers.
The Mayo Clinic Hepatobiliary SPORE has ongoing clinical trials, including a study of MTI-301 in patients with advanced malignancy such as liver cancer and ...
The study will evaluate the efficacy and safety of gevokizumab in treating active ulcers of pyoderma gangrenosum (PG). Participation eligibility. Participant ...
Rochester, Minn. The purpose of this research study is to improve our understanding of normal liver and gallbladder function and liver and gallbladder diseases ...
Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures. · Patent Foramen Ovale ( ...
The Vaccine Research Group at Mayo Clinic, led by Dr. Poland, Dr. Kennedy and Dr. Ovsyannikova researches vaccines, immunity and the threat of infectious ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.